Clinical Trials Browser

Phase 2 × Differentiated Thyroid Cancer × Everolimus × Clear all

NCT01263951 2021-10-26

Study of Everolimus and Sorafenib in Patients With Advanced Thyroid Cancer Who Progressed on Sorafenib Alone

Phase 2 Unknown

EndocrineHead & Neck

Differentiated Thyroid Cancer